Microsoft: Fiscal Q4 Earnings Consensus Estimates

Microsoft (NASDAQ: MSFT) will be reporting their fiscal fourth quarter financials on July 27 after markets close. Analysts have a consensus $306.13 12-month price target on the company, via a total of 40 analysts, with 18 analysts having strong buy ratings. 20 analysts meanwhile have buy ratings and two have hold ratings. The street high sits at a $378 price target, and the lowest target sits at $256.70.

23 analysts have revenue estimates for the fourth quarter. The mean revenue estimate between all 23 analysts is $44.243 billion; this number has been revised upwards from $41.9 billion at the start of the year. The highest revenue estimate is $44.869 billion, while the lowest is $43.629 billion.

Onto EBITDA estimates, there are currently only 5 analysts who have fourth-quarter EBITDA estimates. The mean is currently $20.747 billion, with this number having been revised up from $18.474 billion at the start of the year. Street high is $20.915 billion EBITDA estimate and the lowest is $20.229 billion.

Analysts estimate that quarterly earnings per share will come in at $1.92, with this number being revised upwards from $1.71 at the start of the year. Street high is $2.03 and the lowest estimate is $1.81 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Canadian Copper Strikes $96 Million Financing Deal to Jumpstart Bathurst Project

First Phosphate Gains Danish State Support With LOI For EUR 170 Million Credit Guarantee

Related News

Medipharm Labs: Canaccord Drops Target To Just $0.10

On May 16, Medipharm Labs (TSX: LABS) reported its first quarter financial results. The company...

Tuesday, May 24, 2022, 11:37:00 AM

Canaccord: Canopy USA Transaction Is An Overall Positive

Canopy Growth (TSX: WEED) earlier this week revealed that it would be restructuring its US...

Thursday, October 27, 2022, 03:06:00 PM

Li-Cycle: BMO Cuts Target After Negative Revenues Recorded In Q3

Li-Cycle (NYSE: LICY) recently reported its third-quarter financial results. The company reported revenues of -$2...

Sunday, September 25, 2022, 11:13:00 AM

Cineplex: BMO Reiterates Targets Despite Earnings Missing Consensus

Cineplex Inc. (TSX: CGX) reported its second quarter financial results last week. The company announced...

Monday, August 15, 2022, 12:24:00 PM

Village Farms: Raymond James Raises Price Target To US$27

On August 16, Village Farms (NASDAQ: VFF) (TSX: VFF) announced their entrance into the US...

Friday, August 20, 2021, 03:39:00 PM